IFNG and neoplasm: In addition, the butyrate induces strong production of effector molecules in cytolytic T lymphocytes (CTLs) such as CD25, IFN-γ, and TNF-α, resulting in increased anti-tumor reactivity and improved therapeutic outcomes [99].